2-receptor agonist may also protect against erosive esophagitis” />

Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Cardiology | Gastroenterology | Internal Medicine | Journal

Back to Journal Articles

Famotidine May Prevent Peptic Ulcers in Patients on Aspirin

Last Updated: July 06, 2009.

 

The H2-receptor agonist may also protect against erosive esophagitis

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
The H2-receptor agonist famotidine prevents gastric and duodenal ulcers, as well as erosive esophagitis, in patients taking low-dose aspirin, according to a study published online July 6 in The Lancet.

MONDAY, July 6 (HealthDay News) -- The H2-receptor agonist famotidine prevents gastric and duodenal ulcers, as well as erosive esophagitis, in patients taking low-dose aspirin, according to a study published online July 6 in The Lancet.

Ali S. Taha, M.D., of the University of Glasgow in the United Kingdom, and colleagues conducted a study of 404 adult patients attending cardiovascular, cerebrovascular and diabetes clinics, who were taking 75 to 325 mg/day of aspirin and who did not have ulcers or erosive esophagitis at baseline, of whom 204 were randomized to receive 20 mg of famotidine twice daily, while 200 were given placebo.

After 12 weeks of treatment, seven (3.4 percent) of the famotidine patients developed gastric ulcers, compared to 30 (15.0 percent) of the control group, the investigators found. Duodenal ulcers had developed in 0.5 percent of the treatment group versus 8.5 percent in the control group. Similarly, 4.4 percent of the treatment group and 19.0 percent of the control group were diagnosed with erosive esophagitis, the researchers discovered, and the patients in the treatment group had fewer adverse events.

"There is little doubt that aspirin and other anti-clotting drugs are very useful in the prevention of heart, brain, and other vascular diseases," the authors said in a statement. "However, everybody should be aware that aspirin use can also be associated with a variety of gastrointestinal or digestive system problems, which sometimes can be serious. The results of this research widen the options for the prevention of such problems."

Abstract
Full Text (subscription or payment may be required)
Comment (subscription or payment may be required)

Copyright © 2009 ScoutNews, LLC. All rights reserved.


Previous: Husband Migration Affects Mexican Wives' Mental Health Next: Prostate Condition Symptoms Linked to Ejaculation Problems

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2013
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.